NCT06628414

Brief Summary

Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression. Treatment options are limited and do not address tinnitus directly (e.g., reduce its loudness). To do that, we must change brain activity causing tinnitus. Low-dose electrical stimulation, using a technique called transcranial Direct Current Stimulation (tDCS), is a promising approach. The technique is safe and easy to administer. Several small studies have tested tDCS for tinnitus showing some benefits. To assess whether these benefits will generalise to other patients, we need to conduct a randomised controlled trial - a large, rigorously controlled experiment based on prior agreed procedures. Clinical trials are expensive and time-consuming to run and thus require meticulous pilot work to establish the most effective treatment regimens and the most sensitive measures of treatment outcome. The current study aims to provide such pilot information for a clinical trial of tDCS treatment of tinnitus. Using a total of 40 patients, we will establish how to best to administer tDCS and measure resulting changes in tinnitus perception and associated brain activity. The current study is a crucial first step towards determining whether or not tDCS can effectively treat tinnitus.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Dec 2024Sep 2026

First Submitted

Initial submission to the registry

September 27, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

September 27, 2024

Last Update Submit

February 9, 2026

Conditions

Keywords

tinnitusbrain stimulationneuromodulationtranscranial direct current stimulation

Outcome Measures

Primary Outcomes (1)

  • Proof of concept

    Measured by protocol compliance and attrition

    Assessed at study end (anticipated as 1 year after study start)

Secondary Outcomes (7)

  • Tinnitus symptom severity

    Before first intervention session, after final intervention session and at 3-month follow-up

  • Tinnitus loudness

    Before first intervention session, after each intervention session and at 3-month follow-up (VAS). Before first intervention session and after final intervention session (loudness matching)

  • Depression

    Before first intervention session, after final intervention session and at 3-month follow-up

  • Anxiety

    Before first intervention session, after final intervention session and at 3-month follow-up

  • Treatment satisfaction

    After final intervention session and at 3-month follow-up

  • +2 more secondary outcomes

Study Arms (2)

Transcranial Direct Current Stimulation (tDCS)

EXPERIMENTAL

TDCS will be delivered using a NeuroConn DC Stimulator Plus via two 35cm2 rubber electrodes covered in saline-soaked sponges. The anode electrode will be positioned over EEG 10-20 coordinate F4 and the cathode over F3. The current will be delivered at 2mA for 20 minutes with ramp-up and ramp-down of 10 seconds. Each participant will receive 10 daily stimulation sessions over 2 weeks.

Device: transcranial Direct Current Stimulation

Sham

PLACEBO COMPARATOR

Same as intervention arm but the current will be delivered at 2mA for 30 seconds, after which the stimulation will be discontinued.

Device: transcranial Direct Current Stimulation

Interventions

transcranial Direct Current Stimulation

ShamTranscranial Direct Current Stimulation (tDCS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 or over
  • Suffering from subjective idiopathic tinnitus
  • Sufficient understanding of English to be able to provide informed consent
  • Able to safely undergo tDCS

You may not qualify if:

  • Aged under 18
  • Not suffering from tinnitus or suffering from objective tinnitus
  • Insufficient understanding of English to be able to provide informed consent
  • Unable to safely undergo tDCS as assessed by tDCS Safety Questionnaire
  • Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nottingham

Nottingham, United Kingdom

RECRUITING

MeSH Terms

Conditions

Tinnitus

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Magdalena Sereda, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Statistician
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Double-blind, parallel, randomised, sham-controlled pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 27, 2024

First Posted

October 8, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations